Plain-English translation of NCT07002892 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Carpal tunnel syndrome causes pain, numbness, and tingling in the hand and wrist. This trial is testing whether three different injection treatments work equally well: betamethasone (a steroid), dextrose (a type of sugar), or ozone gas. All three are injected directly around the median nerve in the wrist using ultrasound guidance to help the doctor see exactly where to place the needle.
Many people with moderate carpal tunnel syndrome don't improve with conservative treatments like splinting and rest. Doctors need to know which injection treatment is most effective and safe for these patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups. You will receive one injection of your assigned treatment directly into the carpal tunnel region in your wrist under ultrasound guidance. After the injection, you will wear a wrist splint for 8 hours daily during the follow-up period. A doctor who doesn't know which treatment you received will evaluate your results afterward to keep the study fair.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Yunus Burak Bayır
Enrollment target
~72 participants
Started
January 2025
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
YUNUS BURAK BAYIR, SPECİALİST
Ankara Etlik City Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.